Prefer Injectable Peptides Based on Personal Research and Practitioner Guidance: Some individuals, after thorough research and consultation with knowledgeable practitioners, conclude that injectable BPC-157 better aligns with their goals due to potential bioavailability advantages
The difference in bacteremia relapse between the two groups was 0.4 percentage points (95% CI, -0.6 to 1.4) and the median number of antibiotic-free days by day 28 was higher in the seven-day group than in the 14-day group
My assumption is that, within the next 12-18 months, we will get something from [big] pharma and the FDA stating that a select amount [of peptides] will most likely be deemed Class 1 [from their current Class 2], which will mean that theyre legal to compound [in the U.S
Fragment 176-191, CJC-1295 & Ipamorelin Investigations of Synergistic Actions When studied together, Ipamorelin and CJC-1295 appear to demonstrate complementary dynamics in laboratory models
Usually mild and diminishing with continued use
Expected timeline: Faster onset than topical-only
